Ding Dong is the Skinny Label (Effectively) Dead?
FDA Law Blog
SEPTEMBER 6, 2021
Teva received tentative approval in June 2003 and launched in 2007 after a blocking patent expired. Instead, it was GSK who erred in omitting the post-MI language from the use code. Especially now with the utility of the use code minimized. But what is a “true carve-out?”
52 
Let's personalize your content